Zimmer Biomet Holdings has filed documents with the SEC, disclosing that it successfully signed two new revolving credit agreements on June 26, 2026.

One of the agreements has a term of five years, while the other has a term of 364 days. This move marks a significant update to the company’s financial structure, aimed at enhancing the flexibility and efficiency of its working capital management. Revolving credit arrangements provide enterprises with the convenience of borrowing, repaying, and borrowing again within an agreed limit at any time, making them a common financial tool for large companies to optimize cash flow and capital structure.